Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01518881
Recruitment Status : Terminated (Corporate decision to reformulate the investigational product.)
First Posted : January 26, 2012
Last Update Posted : January 9, 2014
United States Department of Defense
Information provided by (Responsible Party):
Arbutus Biopharma Corporation

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2012
  Study Completion Date : July 2012